Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Sironax describes new ferroptosis inhibitors

Sep. 30, 2021

Restored ciliogenesis switches glioma stem cells from self-renewal to differentiation

Sep. 30, 2021

Point Biopharma reports preclinical data on FAP-alpha inhibitor program

Sep. 29, 2021

RARA identified as a druggable target for pediatric acute myeloid leukemia

Sep. 29, 2021

New KDM1A inhibitors discovered at Shenyang Pharmaceutical University

Sep. 29, 2021

Peking University presents new boron-carrying agents

Sep. 29, 2021

Shanghai Zheye Biotechnology divulges G12C mutant GTPase KRAS inhibitors

Sep. 29, 2021

Diaprost licenses theranostic antibody hu5A10 to Radiopharm

Sep. 28, 2021

RNA therapeutic MC-30 shows efficacy in rodent models of HNSCC

Sep. 28, 2021

Ninjurin-1-associated eRNA linked to glioblastoma multiforme

Sep. 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.